GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The objective of the GRAVITAS trial is to determine whether tailored anti-platelet therapy using the Accumetrics VerifyNow P2Y12 assay reduces major adverse cardiovascular events after drug-eluting stent implantation.
Epistemonikos ID: bf8a12b37d487a6a439780e168b70fa4cbf23547
First added on: May 04, 2024